Abstract
Inflammation in Parkinson’s disease (PD) is a continuous process and might be implicated in the progression of neuronal degeneration. Taking this into account, we proposed a new protocol with multiple and consecutive intranigral lipopolysaccharide (LPS) administration in order to analyze its effects on cognitive behavior. Additionally, striatal concentrations of the neurotransmitters dopamine (DA) and serotonin and their respective metabolites were assessed in three different time-points with the purpose of identifying the consecutive and cumulative effects of LPS infusions. We demonstrated that with a minimum administered dose there was stabilization of neuronal damage as revealed by absence of synergic effect on DA concentration. Although the DA decrease (–43%) generates an animal model of early phase of PD, without apparent motor impairment, the LPS group exhibited deficit in episodic-like memory behavior from the first time-point until the last one, indicating persisted disturbances in memory-recognition responses. These findings provide evidence that multiple intranigral LPS infusions are not sufficient to cause cumulative and progressive damage to dopaminergic neurons, but confirm that the LPS model can be adopted as a useful tool providing insight about the cognitive impairment observed in pre-motor phase of PD.
Keywords: Parkinson’s disease, lipopolysaccharide, cognitive impairment, novel-object recognition test.
CNS & Neurological Disorders - Drug Targets
Title:Multiple Intranigral Unilateral LPS Infusion Protocol Generates a Persistent Cognitive Impairment without Cumulative Dopaminergic Impairment
Volume: 12 Issue: 7
Author(s): Ana Marcia Delattre, Bruno Carabelli, Marco Aurélio Mori, Claudia Pudell, Danielle R.B.L. da Silva, Isabela Menezes, Paula R.G. Kempe, Pedro Vinícius Staziaki, Patrícia A. Dombrowski, Claudio da Cunha, Marcelo M.S. Lima and Anete C. Ferraz
Affiliation:
Keywords: Parkinson’s disease, lipopolysaccharide, cognitive impairment, novel-object recognition test.
Abstract: Inflammation in Parkinson’s disease (PD) is a continuous process and might be implicated in the progression of neuronal degeneration. Taking this into account, we proposed a new protocol with multiple and consecutive intranigral lipopolysaccharide (LPS) administration in order to analyze its effects on cognitive behavior. Additionally, striatal concentrations of the neurotransmitters dopamine (DA) and serotonin and their respective metabolites were assessed in three different time-points with the purpose of identifying the consecutive and cumulative effects of LPS infusions. We demonstrated that with a minimum administered dose there was stabilization of neuronal damage as revealed by absence of synergic effect on DA concentration. Although the DA decrease (–43%) generates an animal model of early phase of PD, without apparent motor impairment, the LPS group exhibited deficit in episodic-like memory behavior from the first time-point until the last one, indicating persisted disturbances in memory-recognition responses. These findings provide evidence that multiple intranigral LPS infusions are not sufficient to cause cumulative and progressive damage to dopaminergic neurons, but confirm that the LPS model can be adopted as a useful tool providing insight about the cognitive impairment observed in pre-motor phase of PD.
Export Options
About this article
Cite this article as:
Delattre Marcia Ana, Carabelli Bruno, Mori Aurélio Marco, Pudell Claudia, Silva R.B.L. da Danielle, Menezes Isabela, Kempe R.G. Paula, Staziaki Vinícius Pedro, Dombrowski A. Patrícia, Cunha da Claudio, Lima M.S. Marcelo and Ferraz C. Anete, Multiple Intranigral Unilateral LPS Infusion Protocol Generates a Persistent Cognitive Impairment without Cumulative Dopaminergic Impairment, CNS & Neurological Disorders - Drug Targets 2013; 12 (7) . https://dx.doi.org/10.2174/18715273113129990074
DOI https://dx.doi.org/10.2174/18715273113129990074 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammation in Fish As Seen from A Morphological Point of View with Special Reference to the Vascular Compartment
Current Pharmaceutical Design Development, Characterization and in vivo Localization Study of Topical 5-Fluorouracil Gels: A Comparative Study with Conventional Formulation
Current Drug Delivery Patient Involvement and Shared Decision-Making in Mental Health Care
Current Clinical Pharmacology The Psychoactive Effects of Aromatic Amino Acids
Current Nutrition & Food Science Modulation of Cell Death in Age-Related Diseases
Current Pharmaceutical Design Advanced Magnetic Resonance Imaging Techniques in the Preterm Brain: Methods and Applications
Current Pediatric Reviews Identifying Coevolution Between Amino Acid Residues in Protein Families: Advances in the Improvement and Evaluation of Correlated Mutation Algorithms
Current Bioinformatics Critical Role of Computer Simulations in Drug Discovery and Development
Current Topics in Medicinal Chemistry The Surgical Management of Parkinson's Disease
CNS & Neurological Disorders - Drug Targets A Role of GABA Analogues in the Treatment of Neurological Diseases
Current Medicinal Chemistry Pharmacogenetic and Pharmacogenomic Research in Psychiatry: Current Advances and Clinical Applications
Current Pharmacogenomics Structural Studies of the Klentaq1 DNA Polymerase
Current Organic Chemistry Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review
Recent Patents on Drug Delivery & Formulation Metabolomics
Current Drug Metabolism Retropharyngeal Abscess: Diagnosis and Treatment Update
Infectious Disorders - Drug Targets Antiprotozoal Agents: An Overview
Anti-Infective Agents in Medicinal Chemistry In Vivo Experimental Models of Epilepsy
Central Nervous System Agents in Medicinal Chemistry Paving the Way to Personalized Genomic Medicine: Steps to Successful Implementation
Current Pharmacogenomics and Personalized Medicine Inflammation, High Density Lipoprotein and Endothelium
Current Medicinal Chemistry Suppression of Inflammatory and Allergic Responses by Pharmacologically Potent Fungus Ganoderma lucidum
Recent Patents on Inflammation & Allergy Drug Discovery